QantX has awarded Matthew Bone, CEO of Molydyn, a £25,000 Blavatnik Prize for Innovation to support commercial trials and further development of his newly released Atlas platform.
Computational tools have shown extreme benefits for biological sciences and drug development. However, material science as a sector has low uptake of chemical modeling approaches due to a skills gap, with the growth of AI in biology capturing experienced computational scientists and funding.
Molydyn is supporting material scientists, democratising access to powerful tools with the potential to significantly reduce wasted time and resources by reducing the number of experiments required. Their beachhead product “Atlas”, launched in September 2022, simplifies the use of LAMMPS, an open-source molecular dynamics simulator, and allows material scientists to access this complex modeling software on a low-cost pay-as-you-go basis.
“The Blavatnik prize for Innovation will really help us to develop the next stage of our simulation technology, as we optimise our tools for commercial grade materials. We’re thankful to QantX for their support and look forward to working with them to help drive sustainable materials discovery.” – Matthew Bone, Molydyn
We’re excited to support Matthew in this part of his journey as he tests his business model and grows the proposition.
“There is on-going need for new materials discovery in relation to many aspects of industry, perhaps most pressingly in relation to new ways of dealing with the climate emergency. However, discovery cycles in this industry are slow and cumbersome. Matthew Bone of Molydyn has impressed us with his vision of solving this problem with the use of modern digital tools. The Blavatnik Prize for Innovation is please to support their initiative in bringing these tools to market and ultimately helping to solve significant global challenges” – Richard Haycock, CEO QantX
Matthew Bone, CEO of Molydyn and winner of a Blavatnik Prize for Innovation